Central Florida Clinical Studies Inc is categorized under Family Practice Doctors in Ocoee, FL and active since 1993.
Central Florida Clinical Studies Inc was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Antonio Caos at the company’s single location by writing to 10000 West Clnl Drive # 289, Ocoee, Florida FL 34761 or by phoning (407) 296-1916. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Central Florida Clinical Studies Inc |
Contact Person: | Antonio Caos |
Address: | 10000 West Clnl Drive # 289, Ocoee, Florida 34761 |
Phone Number: | (407) 296-1916 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Central Florida Clinical Studies Inc was started in 1993 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Antonio Caos for inquiries that concern Central Florida Clinical Studies Inc by calling the company number (407) 296-1916, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Clinical Studies Inc can be found at the coordinates 28.551588,-81.52762 as well as the street address 10000 West Clnl Drive # 289 in Ocoee, Florida 34761.
For its online presence, you may visit Central Florida Clinical Studies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.